Fields »
ABOUT
HELP
BLOG

144 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 3

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
SLC52A3Solute carrier family 52 (riboflavin transporter), member 3
Stomach cancer: 5.51e-6
Tissue enhancedtestis:62.2
SLC9B2Solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2
Nucleoplasm
Cell Junctions		Tissue enhancedcerebral cortex:32.6
SLCO1A2Solute carrier organic anion transporter family, member 1A2
Plasma membraneTissue enhancedcerebral cortex:28.8
SPPL2ASignal peptide peptidase like 2A
VesiclesExpressed in all
SURF4Surfeit 4
Head and neck cancer: 1.47e-5
Breast cancer: 5.85e-4
Liver cancer: 8.11e-4
Expressed in all
TAP2Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
Nuclear speckles
Endoplasmic reticulum		Renal cancer: 5.22e-8
Pancreatic cancer: 1.51e-4
Mixed
TAS2R60Taste receptor, type 2, member 60N/A
Not detected
TCIRG1T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
MitochondriaRenal cancer: 1.50e-11
Urothelial cancer: 9.45e-6
Expressed in all
TM6SF1Transmembrane 6 superfamily member 1N/A
Intermediate filamentsRenal cancer: 6.79e-4
Mixed
TM6SF2Transmembrane 6 superfamily member 2N/A
Group enriched5duodenum:79.1
small intestine:78.4
TM7SF2Transmembrane 7 superfamily member 2
Endoplasmic reticulum
Vesicles		Renal cancer: 8.49e-8
Expressed in all
TMBIM1Transmembrane BAX inhibitor motif containing 1
VesiclesRenal cancer: 3.38e-4
Pancreatic cancer: 4.22e-4
Expressed in all
TMC5Transmembrane channel-like 5
Nucleus
Plasma membrane		Liver cancer: 7.96e-4
Tissue enhancedsmall intestine:60.2
TMEM117Transmembrane protein 117N/A
Melanoma: 3.94e-4
Mixed
TMEM161ATransmembrane protein 161A
CytosolStomach cancer: 2.99e-4
Expressed in all
TMEM161BTransmembrane protein 161BN/A
Expressed in all
TMEM175Transmembrane protein 175
Nucleus
Nuclear membrane		Pancreatic cancer: 9.85e-5
Expressed in all
TMEM181Transmembrane protein 181
Golgi apparatus
Vesicles		Ovarian cancer: 1.09e-4
Cervical cancer: 7.26e-4
Expressed in all
TMEM184CTransmembrane protein 184C
Nucleoplasm
Vesicles		Renal cancer: 2.31e-7
Pancreatic cancer: 6.37e-4
Group enriched5parathyroid gland:253.7
thyroid gland:54.5
TMEM185ATransmembrane protein 185AN/A
Endoplasmic reticulumExpressed in all
TMEM185BTransmembrane protein 185BN/A
Endoplasmic reticulumLiver cancer: 5.71e-7
Endometrial cancer: 4.96e-6
Colorectal cancer: 5.44e-4
Expressed in all
TMEM260Transmembrane protein 260
Nucleus
Focal adhesion sites
Cytosol		Lung cancer: 7.11e-4
Tissue enhancedcervix, uterine:63.2
TMEM39BTransmembrane protein 39B
VesiclesRenal cancer: 5.11e-9
Liver cancer: 2.82e-6
Endometrial cancer: 3.00e-4
Mixed
TMEM45BTransmembrane protein 45B
Nucleoplasm
Cytosol		Tissue enhancedduodenum:140.0
small intestine:141.9
TMEM86ATransmembrane protein 86A
Mixed
TRAM1Translocation associated membrane protein 1
Cervical cancer: 2.06e-4
Renal cancer: 7.79e-4
Expressed in all
TRAM1L1Translocation associated membrane protein 1-like 1N/A
MitochondriaMixed
TRPC1Transient receptor potential cation channel, subfamily C, member 1
VesiclesRenal cancer: 2.72e-5
Mixed
TRPC3Transient receptor potential cation channel, subfamily C, member 3N/A
Tissue enhancedsmooth muscle:4.1
TRPC6Transient receptor potential cation channel, subfamily C, member 6
Nucleoplasm
Cytosol		Tissue enhancedplacenta:29.8
TRPM1Transient receptor potential cation channel, subfamily M, member 1
Nucleoplasm
Cytosol		Group enriched27skin:4.8
testis:2.5
UBIAD1UbiA prenyltransferase domain containing 1
VesiclesRenal cancer: 6.80e-5
Expressed in all
VN1R2Vomeronasal 1 receptor 2N/A
Mixed
VN1R4Vomeronasal 1 receptor 4N/A
Not detected
WFS1Wolfram syndrome 1 (wolframin)
Endometrial cancer: 1.13e-6
Thyroid cancer: 3.13e-4
Mixed
WLSWntless Wnt ligand secretion mediator
Endoplasmic reticulumRenal cancer: 3.67e-7
Urothelial cancer: 3.51e-4
Breast cancer: 4.03e-4
Ovarian cancer: 9.43e-4
Expressed in all
XKX-linked Kx blood group
Nucleoplasm
Vesicles
Mitochondria		Mixed
XKR3XK, Kell blood group complex subunit-related family, member 3N/A
Tissue enriched80testis:14.3
XKR6XK, Kell blood group complex subunit-related family, member 6N/A
Mixed
XKR7XK, Kell blood group complex subunit-related family, member 7N/A
Tissue enriched10cerebral cortex:3.6
XKR8XK, Kell blood group complex subunit-related family, member 8N/A
Golgi apparatusBreast cancer: 8.63e-4
Expressed in all
XKR9XK, Kell blood group complex subunit-related family, member 9
MitochondriaPancreatic cancer: 7.20e-4
Tissue enhancedtestis:14.1
XPR1Xenotropic and polytropic retrovirus receptor 1
Endoplasmic reticulum
Golgi apparatus		Liver cancer: 3.04e-4
Expressed in all
XXbac-BPG246D15.9
Nuclear speckles
Endoplasmic reticulum		Tissue enhancedappendix:16.0
spleen:9.7

« prev | Page of 3

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.